Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer PFE will report its third-quarter 2025 earnings on Nov. 4, before market open. The Zacks Consensus Estimate for sales ...

The move, announced Thursday, escalates the competition between the two pharmaceutical giants for a critical advantage in the ...

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $20.0 to $30.0 for Pfizer during the past quarter. Looking at the volume ...

To get a sense of who is truly in control of Pfizer Inc. (NYSE:PFE), it is important to understand the ownership structure of ...

Pfizer (NYSE: PFE) continues to lag the market. Over the past few years, the company has generally reported declining revenue and profits, resulting in a substantial decline in market value. The ...

Pfizer will reduce prices on drugs sold to Medicare patients. The Trump administration has made cutting prescription drug prices a priority. Ultimately, the administration aims to have Americans ...

Remember Pfizer (NYSE: PFE), the giant pharmaceutical company that developed a COVID-19 vaccine within weeks of the pandemic hitting U.S. shores and got it approved within a year? It was the fastest ...

Pfizer stock offers a yield above 6% at recent prices. MPLX LP is a pipeline operator that offers a yield above 7% at the moment. Pfizer and MPLX LP could continue raising their dividend payouts for ...